Raji, Annaswamy

Body Fat Distribution and Insulin Resistance in Healthy Asian Indians and Caucasians

Raji, A., Seely, E. W., Arky, R. A., & Simonson, D. C. (2001) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 541

Insulin Resistance and Vascular Dysfunction in Nondiabetic Asian Indians

Raji, A., Gerhard-Herman, M. D., Warren, M., Silverman, S. G., Raptopoulos, V., Mantzoros, C. S., & Simonson, D. C. (2004) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Disease Prevention

Cited by 98

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial

Dagogo-Jack, S., Pratley, R. E., Cherney, D. Z. I., McGuire, D. K., Cosentino, F., Shih, W. J., Liu, J., Frederich, R., Mancuso, J. P., Raji, A., et al. (2021) · BMJ Open Diabetes Research & Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 37

Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus

Heymsfield, S. B., Raji, A., Gallo, S., Liu, J., Pong, A., Hannachi, H., & Terra, S. G. (2020) · Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 21